The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Deicken, R. F.
* Articles by Weiner, M. W.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Deicken, R. F.
* Articles by Weiner, M. W.

Am J Psychiatry 1995; 152:126-129
Copyright © 1995 by American Psychiatric Association


REGULAR ARTICLES

Basal ganglia phosphorous metabolism in chronic schizophrenia

RF Deicken, G Calabrese, EL Merrin, G Fein and MW Weiner
Magnetic Resonance Unit, Department of Veterans Affairs Medical Center, San Francisco, CA 94121.

OBJECTIVE: The authors examined whether there are abnormalities in high- energy phosphorous metabolism in the basal ganglia of schizophrenic patients. METHOD: In vivo 31P magnetic resonance spectroscopic imaging was performed on 18 chronic schizophrenic patients and 16 healthy comparison subjects. The percentages of total phosphorous signal for phosphomonoesters, inorganic phosphate, phosphodiesters, phosphocreatine, and beta-ATP were calculated. RESULTS: The mean percentages of beta-ATP signal in the right and left basal ganglia were significantly lower for the schizophrenic patients than for the comparison group. No other group differences in phosphorous metabolites and no lateral asymmetries in the schizophrenic group were noted. CONCLUSIONS: This preliminary study provides support for abnormal high- energy phosphorous metabolism in the basal ganglia of schizophrenic patients.


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
P. HeiSer, F. Enning, J.-C. Krieg, and H. Vedder
Effects of haloperidol, clozapine and olanzapine on the survival of human neuronal and immune cells in vitro
J Psychopharmacol, November 1, 2007; 21(8): 851 - 856.
[Abstract] [PDF]


Home page
Am. J. PsychiatryHome page
P. F. Renshaw, A. M. Parow, F. Hirashima, Y. Ke, C. M. Moore, B. deB. Frederick, M. Fava, J. Hennen, and B. M. Cohen
Multinuclear Magnetic Resonance Spectroscopy Studies of Brain Purines in Major Depression
Am J Psychiatry, December 1, 2001; 158(12): 2048 - 2055.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
H. Fukuzako, T. Fukuzako, T. Hashiguchi, S. Kodama, M. Takigawa, and T. Fujimoto
Changes in Levels of Phosphorus Metabolites in Temporal Lobes of Drug-Naive Schizophrenic Patients
Am J Psychiatry, August 1, 1999; 156(8): 1205 - 1208.
[Abstract] [Full Text]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
T. Kato, T. Inubushi, and N. Kato
Magnetic Resonance Spectroscopy in Affective Disorders
J Neuropsychiatry Clin Neurosci, May 1, 1998; 10(2): 133 - 147.
[Abstract] [Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 1995 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org